Global Adapalene Market Size, Share, Trends, And Forecast, 2026-2033 Combination Therapies And Rising Acne Prevalence Fuel 3.9% CAGR, Reaching USD 789.5 Million By 2033

(MENAFN- GlobeNewsWire - Nasdaq) New Report Added to Research and Markets values the global adapalene market at $605.5m in 2025, with combination therapies and maintenance use widening demand, though modest growth leaves Galderma, Teva, Glenmark and Sun Pharmaceutical fighting for share

Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Adapalene Market Size, Share & Trends Analysis Report by Formulation, Drug Composition, Prescription, Indication, Distribution Channel, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

Global Adapalene Market to Reach USD 789.5 Million by 2033 as Demand for Acne Treatment Increases

The global adapalene market was valued at an estimated USD 605.5 million in 2025 and is projected to reach USD 789.5 million by 2033, expanding at a compound annual growth rate of 3.9% from 2026 to 2033. According to the report, market growth is supported by the rising prevalence of acne and other dermatological conditions, greater awareness of skin health, improved access to dermatology services, and increased adoption of topical retinoid therapies.

Adapalene is a third-generation topical retinoid widely prescribed for mild-to-moderate acne vulgaris. Its established efficacy and favorable safety profile have supported broad clinical adoption in both monotherapy and combination treatment regimens. Pharmaceutical companies are also expanding the availability of adapalene formulations combined with benzoyl peroxide or antibiotics, providing additional options for multidrug acne management.

The increasing global incidence of acne vulgaris remains a primary adapalene market growth driver. A study published by MDPI AG in May 2025 reported that acne affects approximately 9.4% of the global population. Although the condition is especially prevalent among adolescents, incidence is also increasing among adults, particularly women. This expanding patient population is generating sustained demand for clinically established topical acne treatments.

Adult acne represents an important growth opportunity for the market. Persistent and late-onset acne is increasingly reported among people over the age of 25. An article published by MDalgorithms Inc. in August 2025 indicated that approximately one-fifth of adults aged 25-39 continue to experience acne. This trend is expanding the addressable patient base for adapalene, including its use in long-term treatment and acne maintenance therapy.

Lifestyle and environmental factors are further influencing market demand. Urban pollution, dietary changes, hormonal imbalances, and elevated stress levels have been associated with the growing burden of acne across multiple regions. Increased social media engagement and greater attention to personal appearance have also encouraged more consumers to seek professional treatment for acne, post-inflammatory hyperpigmentation, scarring, and related skin concerns. As a result, adapalene is gaining visibility across prescription dermatology and over-the-counter skincare channels.

Ongoing pharmaceutical innovation is expected to strengthen future market expansion. New formulations and adapalene combination products may improve treatment adherence, broaden therapeutic applications, and support adoption among dermatologists and consumers. Increased availability through online pharmacies, hospital pharmacies, retail pharmacies & drug stores is also improving access in developed and emerging markets.

Market Segmentation Covered in the Report

The report provides global, regional, and country-level revenue forecasts and analyzes industry trends from 2021 to 2033. The adapalene market is evaluated by formulation, drug composition, prescription status, indication, distribution channel, and region.

• Formulation: Gels, creams, and lotions
• Drug composition: Adapalene monotherapy and adapalene combination products
• Prescription: Over-the-Counter (OTC) and prescription-based products
• Indication: Acne vulgaris, Post-Inflammatory Hyperpigmentation, Photoaging & Skin Texture Disorders, Follicular Keratinization Disorders, and Acne Maintenance Therapy
• Distribution channel: Online pharmacies, hospital pharmacies, retail pharmacies & drug stores, and others

Regional Adapalene Market Coverage

The report assesses growth opportunities across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). Country-level coverage includes the U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.

North America and Europe continue to benefit from established dermatology infrastructure, strong consumer awareness, and access to prescription and OTC acne therapies. Asia Pacific is expected to present significant growth opportunities as healthcare access expands, disposable incomes rise, and demand for dermatological and aesthetic products increases. Latin America and the Middle East and Africa are also gaining attention due to expanding pharmacy networks and improving awareness of acne treatment options.

Strategic Value of the Report

• Detailed adapalene market estimates and forecasts across major segments and regions
• Analysis of competitive positioning and the market presence of key participants
• Assessment of emerging trends, product innovation, and revenue opportunities
• Segment and regional revenue forecasts to support market evaluation
• Actionable intelligence for strategic planning and effective decision-making
• Insights into competition strategies, market share, and future growth drivers

The report enables pharmaceutical companies, investors, healthcare organizations, and other industry stakeholders to evaluate the evolving adapalene market, identify high-potential segments, monitor competitive developments, and make informed business decisions through 2033.

Key Attributes:

Report Attribute	Details
No. of Pages	108
Forecast Period	2025 - 2033
Estimated Market Value (USD) in 2025	$605.5 Million
Forecasted Market Value (USD) by 2033	$789.5 Million
Compound Annual Growth Rate	3.9%
Regions Covered	Global

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Formulation
1.2.2. Drug Composition
1.2.3. Prescription
1.2.4. Indication
1.2.5. Distribution Channel
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Formulation Outlook
2.2.2. Drug Composition Outlook
2.2.3. Prescription Outlook
2.2.4. Indication Outlook
2.2.5. Distribution Channel Outlook
2.2.6. Regional Outlook
2.3. Competitive Insights
Chapter 3. Adapalene Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Adapalene Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
Chapter 4. Adapalene Market: Formulation Estimates & Trend Analysis
4.1. Formulation Market Share, 2025 & 2033
4.2. Segment Dashboard
4.3. Global Adapalene Market by Formulation Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
4.4.1. Gels
4.4.2. Creams
4.4.3. Lotions
Chapter 5. Adapalene Market: Drug Composition Estimates & Trend Analysis
5.1. Drug Composition Market Share, 2025 & 2033
5.2. Segment Dashboard
5.3. Global Adapalene Market by Drug Composition Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
5.4.1. Adapalene Monotherapy
5.4.2. Adapalene Combination Products
Chapter 6. Adapalene Market: Prescription Estimates & Trend Analysis
6.1. Prescription Market Share, 2025 & 2033
6.2. Segment Dashboard
6.3. Global Adapalene Market by Prescription Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
6.4.1. Over-the-Counter (OTC)
6.4.2. Prescription-based
Chapter 7. Adapalene Market: Indication Estimates & Trend Analysis
7.1. Indication Market Share, 2025 & 2033
7.2. Segment Dashboard
7.3. Global Adapalene Market by Indication Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
7.4.1. Acne Vulgaris
7.4.2. Post-Inflammatory Hyperpigmentation
7.4.3. Photoaging & Skin Texture Disorders
7.4.4. Follicular Keratinization Disorders
7.4.5. Acne Maintenance Therapy
Chapter 8. Adapalene Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Market Share, 2025 & 2033
8.2. Segment Dashboard
8.3. Global Adapalene Market by Distribution Channel Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
8.4.1. Online Pharmacies
8.4.2. Hospital Pharmacies
8.4.3. Retail Pharmacies & Drug Stores
8.4.4. Others
Chapter 9. Adapalene Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
9.5. North America
9.5.1. U.S.
9.5.2. Canada
9.5.3. Mexico
9.6. Europe
9.6.1. UK
9.6.2. Germany
9.6.3. France
9.6.4. Italy
9.6.5. Spain
9.6.6. Denmark
9.6.7. Sweden
9.6.8. Norway
9.7. Asia-Pacific
9.7.1. Japan
9.7.2. China
9.7.3. India
9.7.4. Australia
9.7.5. South Korea
9.7.6. Thailand
9.8. Latin America
9.8.1. Brazil
9.8.2. Argentina
9.9. MEA
9.9.1. South Africa
9.9.2. Saudi Arabia
9.9.3. UAE
9.9.4. Kuwait

Companies Featured

• Galderma S.A.
• Glenmark Pharmaceuticals
• Teva Pharmaceuticals
• Sandoz Group AG
• Sun Pharmaceuticals Industries
• Dr. Reddy's Laboratories
• Cipla Limited
• Lupin Limited
• Torrent Pharmaceuticals
• Zydus Lifesciences Limited
• La Roche-Posay
• Niksan Pharmaceutical
• SoliPharma

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN19102026004107003653ID1111830303